Biomarker for aggressive small clear cell renal cell carcinoma

Therapeutic biomarker for aggressive Xp11.2 translocation renal cell carcinoma

Liquid biopsy - ctDNA, cfDNA, ... etc.

DDX11, ALK, ... etc.

Oncolytic virus (pexa-vec, JX-594) study

Therapeutic strategy development (combinatorial or sequential)

BPH, prostate cancer,....

Postoperative-ileus

Development of therapeutic response prediction model in metastatic clear cell renal cell carcinoma patients using serum multi-omics approach

Bladder cancer: BCG response